A detailed history of Investment Management Corp /Va/ /Adv transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investment Management Corp /Va/ /Adv holds 54 shares of BMY stock, worth $3,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Holding current value
$3,012
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$51.92 - $59.94 $2,803 - $3,236
54 New
54 $3.05 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Investment Management Corp /Va/ /Adv Portfolio

Follow Investment Management Corp /Va/ /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Corp /Va/ /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Corp /Va/ /Adv with notifications on news.